Trials / Unknown
UnknownNCT01301586
A Novel Combination Oral Agent to Treat Acne Vulgaris
A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE SAFETY AND EFFICACY OF A NOVEL ORAL ACNE TREATMENT FOR THE TREATMENT OF ACNE VULGARIS
- Status
- Unknown
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Nexgen Dermatologics, Inc. · Industry
- Sex
- Female
- Age
- 13 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate a novel, combination product for the treatment of acne vulgaris in females
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Doxycycline and S-equol | Oral doxycycline and s-equol twice a day |
| DRUG | Doxycycline | ORAL DOXYCYCLINE TWICE A DAY |
Timeline
- Start date
- 2010-11-01
- Primary completion
- 2011-09-01
- Completion
- 2011-09-01
- First posted
- 2011-02-23
- Last updated
- 2011-02-23
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT01301586. Inclusion in this directory is not an endorsement.